158 related articles for article (PubMed ID: 21172382)
1. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.
Folkenberg M; Callréus T; Svanström H; Valentiner-Branth P; Hviid A
Vaccine; 2011 Feb; 29(6):1180-4. PubMed ID: 21172382
[TBL] [Abstract][Full Text] [Related]
2. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
[TBL] [Abstract][Full Text] [Related]
3. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
[TBL] [Abstract][Full Text] [Related]
4. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
[TBL] [Abstract][Full Text] [Related]
6. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
7. Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain.
Rodríguez-Rieiro C; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J; Iniesta-Fornies D; Barranco-Ordoñez D; Cameno-Heras M; Jiménez-García R
Vaccine; 2011 Feb; 29(6):1332-8. PubMed ID: 21182996
[TBL] [Abstract][Full Text] [Related]
8. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.
Parretta E; Ianniello B; Ferrazin F; Rossi F; Capuano A
Vaccine; 2011 May; 29(20):3708-13. PubMed ID: 21406267
[TBL] [Abstract][Full Text] [Related]
9. Adverse events associated with pandemic influenza vaccines: comparison of the results of a follow-up study with those coming from spontaneous reporting.
Carvajal A; Ortega PG; Sáinz M; Velasco V; Salado I; Arias LH; Eiros JM; Rubio AP; Castrodeza J
Vaccine; 2011 Jan; 29(3):519-22. PubMed ID: 21112311
[TBL] [Abstract][Full Text] [Related]
10. Monitoring adverse events of vaccines against Mexican flu.
van Puijenbroek EP; van Grootheest AC
Int J Risk Saf Med; 2011; 23(2):81-7. PubMed ID: 21673415
[TBL] [Abstract][Full Text] [Related]
11. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
[TBL] [Abstract][Full Text] [Related]
12. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.
Huang WT; Huang WI; Huang YW; Hsu CW; Chuang JH
Vaccine; 2012 Mar; 30(12):2168-72. PubMed ID: 22265861
[TBL] [Abstract][Full Text] [Related]
13. [Pandemic vaccines].
Floret D
Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
[No Abstract] [Full Text] [Related]
14. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
Halsey NA; Griffioen M; Dreskin SC; Dekker CL; Wood R; Sharma D; Jones JF; LaRussa PS; Garner J; Berger M; Proveaux T; Vellozzi C; ; Broder K; Setse R; Pahud B; Hrncir D; Choi H; Sparks R; Williams SE; Engler RJ; Gidudu J; Baxter R; Klein N; Edwards K; Cano M; Kelso JM
Vaccine; 2013 Dec; 31(51):6107-12. PubMed ID: 24120547
[TBL] [Abstract][Full Text] [Related]
15. NSW Annual Adverse Events Following Immunisation Report, 2009.
Mahajan D; Campbell-Lloyd S; Roomiani I; Menzies RI
N S W Public Health Bull; 2010; 21(9-10):224-33. PubMed ID: 21211475
[TBL] [Abstract][Full Text] [Related]
16. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
[TBL] [Abstract][Full Text] [Related]
18. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
[TBL] [Abstract][Full Text] [Related]
19. [Variability in the reporting of adverse reactions to the pandemic and seasonal influenza vaccine: seasons 2009-2010 and 2010-2011. Valencian community, Spain].
Alguacil Ramos AM; Lluch Rodrigo JA; Portero Alonso A; Martín Ivorra R; Pastor Villalba E
Rev Esp Salud Publica; 2012; 86(3):241-51. PubMed ID: 22991081
[TBL] [Abstract][Full Text] [Related]
20. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]